Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

689
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
689
Hypoxia01:23

Hypoxia

2.2K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.2K
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

307
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
307
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

246
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
246
Frequency-dependent Selection01:21

Frequency-dependent Selection

24.1K
When the fitness of a trait is influenced by how common it is (i.e., its frequency) relative to different traits within a population, this is referred to as frequency-dependent selection. Frequency-dependent selection may occur between species or within a single species. This type of selection can either be positive—with more common phenotypes having higher fitness—or negative, with rarer phenotypes conferring increased fitness.
24.1K
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

5.5K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of integrated biological effectiveness of eye plaques with <sup>125</sup>I and <sup>103</sup>Pd photon sources using equivalent uniform RBE-weighted dose.

Medical physics·2025
Same author

Assessment of equivalent uniform RBE-weighted dose in hypofractionated proton therapy for ocular melanoma.

Biomedical physics & engineering express·2025
Same author

Adjuvant Brachytherapy Using Iodine-125 Plaques for Conjunctival Melanoma with Scleral Invasion.

Seminars in ophthalmology·2025
Same author

Biological effectiveness of uniform and nonuniform dose distributions in radiotherapy for tumors with intermediate oxygen levels.

Biomedical physics & engineering express·2024
Same author

Equivalent uniform aerobic dose in radiotherapy for hypoxic tumors.

Physics in medicine and biology·2024
Same author

Equivalent uniform RBE-weighted dose in eye plaque brachytherapy.

Medical physics·2024

Related Experiment Video

Updated: Feb 5, 2026

Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model
08:51

Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model

Published on: November 11, 2022

2.0K

Volume dependence in hypoxia-targeted dose escalation.

Alexei V Chvetsov1, Jing Zeng1, Joseph G Rajendran2

  • 1Department of Radiation Oncology, University of Washington, 1959 NE Pacific Street, Seattle, Washington, 98195-6043, USA.

Medical Physics
|September 8, 2018
PubMed
Summary

Hypoxia-targeted dose escalation in cancer treatment may be optimized by considering tumor volume. Smaller hypoxic tumor volumes may require less escalated dose to achieve the same tumor control probability (TCP), potentially reducing side effects.

Keywords:
TCPcell survivaldose escalationhypoxia

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

9.2K
Induction of Hypoxia in Living Frog and Zebrafish Embryos
08:01

Induction of Hypoxia in Living Frog and Zebrafish Embryos

Published on: June 26, 2017

10.2K

Related Experiment Videos

Last Updated: Feb 5, 2026

Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model
08:51

Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model

Published on: November 11, 2022

2.0K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

9.2K
Induction of Hypoxia in Living Frog and Zebrafish Embryos
08:01

Induction of Hypoxia in Living Frog and Zebrafish Embryos

Published on: June 26, 2017

10.2K

Area of Science:

  • Radiation oncology
  • Medical physics
  • Tumor microenvironment research

Background:

  • Dose painting for tumors often targets hypoxic regions, guided by imaging like PET or MRI to assess the Oxygen Enhancement Ratio (OER).
  • The radiobiological effectiveness of escalating radiation doses to hypoxic areas is influenced by factors beyond just OER, including the volume of these hypoxic regions.

Purpose of the Study:

  • To investigate if the volume of hypoxic regions influences the effectiveness of hypoxia-targeted dose escalation.
  • To determine if hypoxic tumor volume is a critical parameter for optimizing dose escalation strategies in radiation therapy.

Main Methods:

  • Utilized a tumor control probability (TCP) model based on Poisson statistics and the Linear Quadratic (LQ) model for cell survival.
  • Calculated average tumor cell survival and TCP dependence on relative hypoxic volume and dose escalation for conventional (30x2 Gy) and hypofractionated (4x12 Gy) regimens.
  • Employed analytical solutions and numerical simulations for radiobiological parameter analysis in non-small cell lung cancer models.

Main Results:

  • Achieved equal average tumor cell survival and TCP with smaller dose escalations for smaller hypoxic volumes, provided escalation is <50% of the oxygenated dose.
  • Demonstrated that average tumor cell survival and TCP are primarily dependent on hypoxic tumor volume within this dose escalation range.
  • Showed that smaller hypoxic volumes, with fewer clonogens, require lower escalated doses for eradication.

Conclusions:

  • Predicts that tumors with smaller relative hypoxic volumes may need less hypoxia-targeted dose escalation to maintain TCP.
  • Suggests findings can inform dose de-escalation strategies in dose painting, potentially reducing normal tissue complications without compromising TCP.